SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coronavirus / COVID-19 Pandemic
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sam who wrote (7999)8/26/2020 11:26:24 PM
From: Moonray2 Recommendations

Recommended By
Glenn Petersen
kidl

   of 22868
 
The only problem with Abbot's test is that it gives too many false readings.
Looks like improvements have been made:

Abbott Labs receives FDA approval for COVID-19 antigen test

A healthcare professional uses a nasal swab to get a sample, then
that’s placed into the test card. Doctors said during the briefing
that other tests currently being used can give false negatives.

“It took three tests that were negative before we got one that
was real. Why was that? Because some studies a third of PCRs
are a false negative. This is not very good,” Dr. Frank Peacock,
professor of emergency medicine, associate chair, and
research director for the department of emergency
medicine at Baylor College of Medicine, said.

But doctors said this BinaxNOW test is more accurate.

“When you’re negative with this test, you’re done. 1 in 1000
will be wrong,” Peacock said.

More at: wgntv.com

o~~~ O
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News